{"title":"更正“日本患者结肠镜检查时雷马唑仑和咪达唑仑镇静作用的比较：倾向评分匹配分析”。","authors":"","doi":"10.1002/deo2.70059","DOIUrl":null,"url":null,"abstract":"<p>Ogura K, Ichijima R, Ikehara H et al. Comparison of remimazolam and midazolam for sedation during colonoscopy in Japanese patients: A propensity score matching analysis. <i>DEN Open</i> 2024; <b>5</b>: e412.</p><p>In Tables 1 and 2, the <i>N</i> = 206 for the midazolam group and the <i>N</i> = 60 for the remimazolam group are incorrect. The correct numbers are <i>N</i> = 208 and <i>N</i> = 40. Accordingly, the adverse event rate for the remimazolam group in Table 2 is <i>n</i> = 1, 2.5%, and the correct <i>p</i>-value is 0.16.</p><p>The correct Table 1 and Table 2 are as follow.</p><p>We apologize for this error.</p>","PeriodicalId":93973,"journal":{"name":"DEN open","volume":"5 1","pages":""},"PeriodicalIF":1.4000,"publicationDate":"2025-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11745817/pdf/","citationCount":"0","resultStr":"{\"title\":\"Correction to “Comparison of remimazolam and midazolam for sedation during colonoscopy in Japanese patients: A propensity score matching analysis”\",\"authors\":\"\",\"doi\":\"10.1002/deo2.70059\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Ogura K, Ichijima R, Ikehara H et al. Comparison of remimazolam and midazolam for sedation during colonoscopy in Japanese patients: A propensity score matching analysis. <i>DEN Open</i> 2024; <b>5</b>: e412.</p><p>In Tables 1 and 2, the <i>N</i> = 206 for the midazolam group and the <i>N</i> = 60 for the remimazolam group are incorrect. The correct numbers are <i>N</i> = 208 and <i>N</i> = 40. Accordingly, the adverse event rate for the remimazolam group in Table 2 is <i>n</i> = 1, 2.5%, and the correct <i>p</i>-value is 0.16.</p><p>The correct Table 1 and Table 2 are as follow.</p><p>We apologize for this error.</p>\",\"PeriodicalId\":93973,\"journal\":{\"name\":\"DEN open\",\"volume\":\"5 1\",\"pages\":\"\"},\"PeriodicalIF\":1.4000,\"publicationDate\":\"2025-01-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11745817/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"DEN open\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/deo2.70059\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"GASTROENTEROLOGY & HEPATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"DEN open","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/deo2.70059","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
Correction to “Comparison of remimazolam and midazolam for sedation during colonoscopy in Japanese patients: A propensity score matching analysis”
Ogura K, Ichijima R, Ikehara H et al. Comparison of remimazolam and midazolam for sedation during colonoscopy in Japanese patients: A propensity score matching analysis. DEN Open 2024; 5: e412.
In Tables 1 and 2, the N = 206 for the midazolam group and the N = 60 for the remimazolam group are incorrect. The correct numbers are N = 208 and N = 40. Accordingly, the adverse event rate for the remimazolam group in Table 2 is n = 1, 2.5%, and the correct p-value is 0.16.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
